On today's Fast Profits with Money Morning, I'm targeting an IT stock that's solving the healthcare sector's biggest problem.
It goes without saying, healthcare is the industry most impacted by the coronavirus.
And in an industry fraught with the financial and competitive pressures of the pandemic, the back burner often gets reserved for the medical field's most important charges: people.
Medical professionals and their governing executive boards have been stretched so thin simply trying to maintain an economic edge that they have less time than ever to spend with their patients, providing diagnoses, and walking through treatment plans.
That's why companies like this "Fast Profits-approved" stock is more in demand than ever before.
This tech solutions company has been around for years - managing administrative tasks and patient documents, and allotting healthcare providers more time to actually provide quality healthcare. It's companies like this, that take a little bit of the "business" out of the healthcare business, that the world truly needs right now.
And with telehealth expected to be the new normal of the post-COVID-19 world, this stock is bound for a record-setting bull run.
Of course, I'm not just looking at the long-term picture here either.
Shares have already climbed 13% off of last month's earnings announcement, and it's just checked off every box on my technical trading checklist.
Meaning, there's a serious run-up just over the horizon...
So, to help you turn the coming payday into even bigger gains, I've put together a call options trade. Watch the video below for the full details...
The Best Plays to Make This May
Action to Take No. 1: Buy shares of Allscripts Health Care Solutions Inc. (NASDAQ: MDRX) using a limit order of $17.50.
Action to Take No. 2: Buy to open MDRX Sept. 17, 2021 $17 calls (MDRX210917C00017000) using a limit order of $1.80.
As a combination of surging demand, post-earnings headlines, and trader psychology adds barrels through MDRX's recent resistance levels, the above options play could turn the coming 25%-40% climb into what could be our biggest payday this year.
And if you're looking for more opportunities to beef up your portfolio, my friend Tom Gentile has an ace up his sleeve. Well, he's got 10 of them to be exact...
And when the Biden administration's taxes hit your bank account, you'll be glad you jumped on these moneymakers while an ideal buy window was still open.
About the Author
Chris Johnson is a highly regarded equity and options analyst who has spent much of his nearly 30-year market career designing and interpreting complex models to help investment firms transform millions of data points into impressive gains for clients.
At heart Chris is a quant - like the "rocket scientists" of investing - with a specialty in applying advanced mathematics like stochastic calculus, linear algebra, differential equations, and statistics to Wall Street's data-rich environment.
He began building his proprietary models in 1998, analyzing about 2,000 records per day. Today, that database, which Chris designed and coded from scratch, analyzes a staggering 700,000 records per day. It's the secret behind his track record.
Chris holds degrees in finance, statistics, and accounting. He worked as a licensed broker for 11 years before taking on the role of Director of Quantitative Analysis at a big-name equity and options research firm for eight years. He recently served as Director of Research of a Cleveland-based investment firm responsible for hundreds of millions in AUM. He is also the Founder/CIO of ETF Advisory Research Partners since 2007, noted for its groundbreaking work in Behavioral Valuation systems. Their research is widely read by leaders in the RIA business.
Chris is ranked in the top 99.3% of financial bloggers and top 98.6% of overall experts by TipRanks, the track record registry of financial analysts dating back to January 2009.
He is a frequent commentator on financial markets for CNBC, Fox, Bloomberg TV, and CBS Radio and has been featured in Barron's, USA Today, Newsweek, and The Wall Street Journal, and numerous books.
Today, Chris is the editor of Night Trader and Penny Hawk. He also contributes to Money Morning as the Quant Analysis Specialist.